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Essential fatty acid (EF A) deficient rodents demon-
strate abnormal epidermal permeability barrier function 
and differentiation, defects which can be corrected by 
either topical or systemic administration of linoleic acid. 
Since linoleic acid is a precursor of prostaglandins, cor-
rection of the defect in barrier function may either reflect 
a prostaglandin-mediated return toward normal epider-
mal differentiation, or, instead, a direct effect of linoleic 
acid. To test these possibilities severely EFA-deficient 
mice were pretreated daily with indomethacin and/or 
5,8,11,14-eicosatetrayeonic acid, and then placed on nor-
mal (linoleic acid-suppl~mented) diets. Endogenous for-
mation of prostaglandin E2 was determined by thin-layer 
chromatography after transformation into prostaglan-
din B2 with ethanolic-hydrochloric acid. Animals treated 
with both indomethacin and TY A demonstrated substan-
tial reductions in prostaglandin E2 levels in liver and 
skin. Animals replenished with linoleic acid invariably 
demonstrated a rapid return of barrier function toward 
normal whether or not they were blockaded, while non-
replenished animals, with or without inhibition of pros-
taglandin biosynthesis, demonstrated continued deteri-
oration in barrier function. In other experiments, topi-
cally applied linoleic acid rapidly reversed the defect in 
barrier function at the sites of application prior to sys-
temic correction of the EFA deficient state. These results 
suggest that: (1) defective cutaneous barrier function in 
EF A deficiency can be corrected locally without prior 
systemic reversal of the deficiency state; and (2) that 
linoleic acid may play a direct ,role in the epidermal 
permeability barrier independent of its role in prosta-
glandin metabolism. 
Exclusion of linoleic acid' from the diet of weanling rodents 
results in a characteristic, multisystem deficiency state- termed 
essential fatty acid deficiency (EFAD) (reviewed in references 
1 and 2). In EFAD the skin exhibits characteristic abnormalities 
of keratinization and permeability barrier function [2-7). Both 
the skin and multisystem disease in EF AD can be cOlTected by 
topical a.pplications of linoleic acid [8-10). Linoleic acid could 
repair the skin signs of EF AD by increasing endogenous gen-
eration of arachidonic acid and its prostaglandin metabolities, 
which in turn, would normalize both the keratinization process 
and barrier function [5,11]. Or, as an increasing body of evidence 
now asserts, linoleic acid may directly affect barrier function, 
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without the necessity of its further metabolism to arachidonic 
acid and its metabolites [7). 
In this study, we have shown: (1) that both free and esterified 
linoleic acid are capable of improving barrier function locally, 
without prior correction of the systemic deficiency state, and 
(2) that barrier function can be corrected over pharmacologic 
blockade of both the lipoxygenase and cyclo-oxgenase pathways 
of arachidonic acid metabolism. 
METHODS 
Chemicals and Solvents 
Chemicals: The following chemicals, from Sigma Chern. Co., St. 
Louis, Mo., were utilized: indomethacin (1- {p-chlorobenzoyl} -5-meth-
oxy-2-methyl-indole-3-acetic acid) , crystalline; cis-9-cis-12-octadecadi-
enoic acid (linoleic acid), grade III, approx. 99% pure; and cis-9-octa-
decanoic acid (oleic acid) , approx. 99% pure. 
Tetrayenoic acid (TYA) was kindly donated by Hoffman-LaRoche 
Inc., Nutley, N.J. 
Solvents: Ch.loroform and methyl a lcohol, both analytical grades, 
were purchased from Mallinckrodt, Inc., Paris, Ky. Benzene, instra-
analyzed, was obtained from J. T . Baker Chern. Co., Phillipsburg, N.J. 
Animals an.d Diets 
Normal weanling (3-4 weeks old) ICR and hairless (strain HRSjJ 
from Jackson Labs., Bar Harbor, Maine) mice were put on either 
linoleic acid-free or control diets, composed and prepared as previously 
described [12]. Animals were maintained at 27-29°C and given water 
ad libitum. After 8 to 12 weeks all animals on deficient diets exhibi ted 
cutaneous signs of severe EF AD. 
Measurement of Tran.sepidermal Water Loss 
Water loss was measured by passing a stream of dry nitrogen through 
a now cell fiLLed with a cup (0.21 cm' orifice) held againsL Lhe ventral 
surface of the ear [13]. The moisture content in the effl uent was then 
detected by means of an electrolytic water analyzer (Manufacturers 
Engineering and Equipment Corp., Warrington, PA.). All measure-
ments of transepidermal water loss (TEWL) were made bilaterally at 
the same time each day, and under identical conditions of environmen-
tal temperature and humidity. Although water loss varied from animal 
to anima l, [01' a given animal the water loss on contralateral eal's 
correlated closely. 
The results of the transepidermal water loss measurements in the 
various groups were compared statistically by Student's (-test. 
Lipid Extraction and Analysis 
At the termination of experiments, full-thickness skins and livers of 
both control and experimental animals were removed under ether 
anesthesia. Tissues were minced into 1-to-2 mm :) pieces in iced phos-
phate-buffered saline and then transferred to a ground glass homoge-
nizer and extracted overnight with chloroform: methanol:water (2:4:1.6, 
v/v/v) using the procedure of Bligh and Dyer [14] at a ratio of 
approximately 1 ml of solvent to 10 to 15 mg of tissue [15]. After 
thorough homogenization, the suspension was re-extracted with fresh 
~ol vent and agit.ated in a modified Bu .... el w .. isL-action shaker for an 
additiona l 30 min at room temperature. The extraction media were 
converted to a 2-phase system with equal volumes of chlo .. oform and 
water, again according to Bligh and Dyer, and the phases were sepa-
rated by low-speed centrifugation. Subsequently, the upper aqueous 
phases were discarded and the combined lower phases washed with 
clean upper phase solvent from the 2-phase system (chloroform:meth-
anol:water, 4:4:3.6, v/v/v). The combined lower phases were then 
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evaporated to dryness in a nitrogen atmosphere, weighed, re-suspended 
in absolute benzene, and stored at -20°C. 
We obtained fatty acid methyl esters of total hepatic lipids as 
previously described (4). The quantit ies of fatty acid methyl esters in 
contro l and in essential fatty ac id-deficient animals were expressed as 
molru' ratios of various fatty acid methyl esters to levels of pa lmi t ic 
acid, which vru'ied only sligh tly in contr ol versus deficient animals 
(reference 4, 5.55 versus 5.06). A ra tio of eicosatrienoic to ru'achidonic 
acid of greater than 0.4 is considered diagnostic of essential fatty acid 
deficiency [16). After 8 weeks on the deficient diet, hepatic fatty acids 
exhibited distinctive changes in fatty acid composition [4]. 
Thin-Layer Chromatography of P GEz in Shin and Liver Sp ecimens 
Since PGE2 is a major prostaglandin formed from ru'achidonic acid 
in skin, we decided to assay for its level as a measure of arachidonic 
acid transformation in to PGs. Similar assays were carried out wi th liver 
specimens. T o atta in this objective specimens of skin and liver were 
homogenized in a mixtw-e of chloroform:methanol (2: 1, v:v). After an 
aliquot was first taken for protein determination, the remaining ho-
mogenate was filtered through glass wool to remove debris. T he total 
lipid extract, wi th a known amount of " C-PGE2 added as a standru'd, 
was t hen evaporated to dryness in a rotary evaporator. The residue 
was dissolved in a small volume of chloroform:methanol (1:1, v/ v) and 
r un on activated silica gel G coated thin-layer chromatography plates 
in chloroform:methanol:acetic acid:water (90:8: 1:0.8, v/v/v/v). The de-
veloped plates wer e then placed in a scanner, and the silica gel portions 
corresponding with "'C-P GE2 were scraped into sin tered funnels and 
t he prostaglandins elu ted with chloroform:methanol (1:1, v/ v). 
For further identification, the PGE, elu ted from t he various samples 
and the I·C-PGE2 was transformed into PGB2 by treatment of each 
sample with 3 ml of 0.5 N NaOH in 50% aqueous ethanol at room 
temperatw-e for 30 min as reported previously [17]. Known amounts of 
nonradioactive PGE. were treated similarly. After 30 min, the samples 
were dilu ted with water and then acidified with 6 N HCI to pH 2-3. The 
sampl es wer e next extracted three times with 10 ml of absolute dichlo-
rome thane and the combined extracts were evaporated to dryness 
under ni trogen. Under these condit ions, the E prostaglandins fo rm 
products conta ining the Ilti (l2)· J:J_ 9 keto chromophore by elimination of 
the ll-hydroxy group and isomerization of the result ing double bond 
[18,19]. The dried samples were disso lved in minimal amounts of 
chloroform:methanol (1:1, v/v) , applied to activated silica gel G plates, 
and developed in ether:acetic acid (100:2, v/v) . T he silica gel por tion 
corresponding with "C-PGBz was elu ted as above and dried under 
ni trogen. 
The PGB2 residues were dissolved in ethanol and the absorbance 
read at 278 nm in a Gilford, Model 240 spectrophometer. Estimations 
of PGB. in samples were determined after comparison with a standard 
curve of known amounts of PGB,. Corrections fo r loss were made with 
knowledge of the "C-PGE2 remaining after the entire procedure. Re-
sults are expressed as nanograms of PGB2 per mg of tissue protein. 
Topical Application of Lipids 
Three separate experiments were performed in which deficient and 
control (corn oil-supplemented) ICR anim als, maintained on EFAD 
diets for 8-12 weeks, were divided into 2 groups of 4 to 12 animals each. 
All animals were maintained at 27 to 29°C in a humidified envu'onment 
during these experiments. 
In the first set of experiments, half of the control and half of the 
deficient animals received twice-daily applications of corn oil (20 ILL) or 
linoleic acid (6 mg) to the ven tl'al sul'face of the righ t eru', while the 
contralateral ear was treated similru'ly with twice-daily applications of 
either olive oil (20 ILL) or oleic acid (6 mg). The purity of each fatty 
ac id was checked by thin-layer chromatography against known stan-
dar ds, and each was dissolved in propylene glycol:ethanol prior to 
application (3:7, v/ v) as previously described [20]. Care was taken to 
insure that the solut ions were spread evenly and did not run. Trans-
epidermal water loss determinations were made at least 6 hr after the 
last prior application of oil , and immediately pr ior to the next topical 
treatment. MeasUl'ements were taken from the un treated dorsal sw-face 
of the righ t ear and on corresponding sw-faces of the left ear. At the 
end of each 6 day experiment, the livers of animals in each of the 
experimental groups were excised, pooled, extracted with Bligh-Dyer 
solvents, and analyzed for extent of essential fatty ac id deficiency by 
gas liquid chromatography, as described above. 
Replenishment/Blockade Experiments 
Two separate experiments were performed in which ICR mice, 
exhibi ting signs of severe EFAD, were randomly divided in to groups 
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which received indomethacin, tetrayenoic acid (T YA), or both (see 
below). In one experiment half the animals in each group were refed 
with control diets (linoleic acid-supplemented), while the other half 
remained on deficien t diets. In the second experiment, r eplenishment 
was accomplished both by resumption of the control diets and by 
topical applications of 12 mg of linoleic acid. A control group fed and 
topically treated only with oleic acid served as the nonreplenished 
control group. 
Mice were pretreated for 3 days, and then daily throughout t he 
experiment, wi th intraperitoneal injections of indomethacin (15 mg/ kg 
body wt.) and/ or tetrayenoic acid (30 mg/ kg body wt) . T his dose of 
indomethacin is 30 times higher than that recently demonstrated to 
block prostaglandin synthesis in E FAD rats and about ha lf the dose 
shown to decrease prostaglandin synthesis by 98% in guinea pigs 
(references cited in 21). T he dose ofTYA is comparable to that recently 
shown to inhibit ar achidonic acid to PG conversion in mouse skin in 
vitro [22,23). Injections contained fi na l concentrations of 0.06 % TY A 
and/or 0.03% indomethacin in 24% v/ v dimethylsulfoxide (DMSO) and 
24 % serum in normal saline. T he serum for these experiments had been 
previously obtained by exsanguinating and poo ling the body of severely 
E FAD mice. An addi tional, control group of EFAD mice received daily 
injections with the con trol solution containing equ ivalen t amoll nts of 
DMSO, serum, and saline. 
Transepidermal water loss was measured daily for 4 days over the 
ventral sw-face of the ears of animals in all groups. At the termination 
of the experiments the livers of animals from each group were pooled, 
extracted, and analyzed by gas liquid chromatography for the extent of 
essential fatty acid deficiency [4], and by thin-layer chromatography to 
determine the degr ee of inhibition of the cyclo-oxygenase pathway. 
RESULT S 
Topical R eplenishment Experiments- Linoleic us. Oleic Acid 
G ross ch a n ges wer e apparen t in t h e appearan ce of linoleic 
acid vs. oleic acid-treated ears d u r ing t h e topical replenishmen t 
experimen ts. On days 1, 2, a nd 3 ear s treated wit h lino leic acid 
a ppear ed more n ormal t h a n did t h e con tralateral ears treated 
wit h ole ic acid, but by day 4 t h ese differ en ces were impercep-
t ib le. . 
These gross ch a n ges wer e p aralleled by ch an ges in barrier 
function , again d iffering dependin g on th e lip id treatment. As 
seen in Fig 1 a nd 2 topical application s of olive o il or oleic acid 
produced actual deterioratio n in barrier fu nction . In con trast, 
simultan eous a pplication of corn o il or linole ic acid to t h e 
con t ralateral ear of t h e sam e a nimal produ ced a p a r tial correc-
t ion in barrier function in t h at ear wit hin 2 to 4 days. After 
mul t iple a pplication s, h owever , t h e d iffere nces in water loss 
between t h e 2 g roups began to converge, presumably because 
sufficien t linole ic acid was a bsorb ed even t u ally to system ically 
correct EFAD (Fig 2 ). 
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FIG 1. T ransepidermal water loss deteriorates as linoleic acid is 
withheld from diet. However, when esteri fied linoleic ac id in the form 
of corn oil is applied to the right ear, and esterified oleic acid in the 
form of olive oil to the left ear, a rapid divergence in water loss 
measurements is obvious. 
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Replenishment Over Arachidonic Acid Blochade 
In order to assess whether linoleic acid plays a direct role in 
barrier function or a role secondary to correction of aberrant 
prostaglandin synthesis, severely EF AD animals were replen-
ished while under treatment with indomethacin and/ or TY A. 
As seen in Fig 3, whether or not animals were treated with 
these pharmacologic agents, either systemically or topically 
administered linoleic acid, corrected the defect in TEWL. Thin-
layer chromatography of hepatic and skin lipid extracts con-
fIrmed that both TY A and indomethacin produced a profound 






TEWL (±sld error ) AFTER APPLI CATION of 
LINOLEIC or OLE IC ACID to MOUSE EARS 
CO NTROL 
DA YS 
FIG 2. Transepidermal water loss measurements in severely EFAD 
animals after applications of pure linoleic acid and oleic acid to contra-
lateral ears of same animal. Note that initially both acids transiently 
perturb barrier function, but linoleic acid does so to a lesser extent, and 
begins to correct barrier function by 2 days. The differences between 
the 2 ears are not statistically significant by 4 days, indicating possible 
systemic correction by this time. Control ears are not effected by topical 
applications of either acid. In this experiment, units of transepidermal 
water loss were recorded as raw data (units). 
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FlG 3. Correction of barrier function in EF AD mice by dietary 
replenishment over arachidonic ac id blockade (see text). Note that in 
upper row (non-replenished controls), barrier function of animals in aU 
groups stayed the same or deteriorated substantially. In contrast, 
graphs in t he lower row illustrate that barrier function is corrected 
rapidly by dietary replenishment in all groups, regardless of the type of 
blockade of arachidonic acid metabolism (see text) . 
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Effect of pharmacologic blochade of arachidonic acid metabolism 
on shin and hepatic prostaglandin B" levels 
Tissue Treatment Diet (ng/~~:'~tein) (% change)" 
Skin Vehicle only Deficient 4.4 (-) 
Replenished 270.0 (0%) 
TYA alone Deficient 4.0 (-) 
Replenished 46.0 (-82.9%) 
Indo alone Deficient Not doneb (-) 
Replenished 17.1 (-93.6%) 
Indo + TYA Deficient 3.75 (-) 
Replenished 46.8 (-82.6%) 
Liver Vehicle only Deficient 8.3 (-) 
Replenished 583.3 (0%) 
TYA alone Deficient 3.5 (-) 
Replenished 33.0 (-94.3%) 
Indo alone Deficient Not doneb (-) 
Replenished 35.4 (-93.8%) 
Indo + TYA Deficient 4.82 (-) 
Replenished 30.2 (-94.8%) 
" Expressed as percent reduction of PGB2 in each group in compar-
ison to vehicle-treated, replenished group. 
/, There were no surviving mice in this group. 
DISCUSSION 
Linoleic Acid in the Epidermal Permeability B arrier 
Linoleic acid deprivation leads to a characteristic deficiency 
syndrome (EFAD), characterized in rodents by abnormal ker-
atinization and enhanced transepidermal water loss [3,6,7]' EF A 
epidermis is thickened and exhibits increased DNA synthesis 
[5,6]. It has been suggested that the increased porosity of EF AD 
epidermis is due to aberrant keratinization, which is, in t ill·n, 
leads secondarily to release from prostaglandin inhibition of 
cell division . But a bundant evidence is now available which 
indicates that the abnormal keratinization and defective barrier 
function of EFAD epidermis are divergent phenomena . Recent 
work has demonstrated defective deposit ion of intercellular, 
neutral lipids in EF AD mouse stratum corneum and stratum 
granulosum [4]. That the important lipid for barrier function is 
linoleic acid itself, and not prostaglandins, is supported by 
several observations: Al though topically applied prostaglandins 
reduce the scaling of EFAD epidermis ell] , they are less effec-
tive than linoleic acid in reducing defective barrier function 
[24]. Topical linoleic acid, but not oleic acid, also repairs ab-
normal barrier function in detergent-treated skin [25]. More-
over, topical linoleic acid corrects EF AD banier fun ction when 
the biosynthesis of prostaglandins is inhibited [26], and de-
creases EF AD hyperplasia without return of prostaglandin 
levels to normal [20). Finally, linoleic acid-containing lipids 
have been found to both impede water loss across experimental 
burn wounds a nd as a monomolecular film in vitro [27]. 
The studies reported here lend further support to this emerg-
ing hypothesis. First, topically applied linoleic acid rapidly 
corrected the defect in barrier function in EF AD mice, while 
oleic acid caused actual deterioration in the same animal. 
Although the more gradual correction of barrier function on the 
oleic acid-treated side presumably reflects sufficient systemic 
absorption of linoleic acid to initiate systemic reversal of the 
defIciency state, direct evidence of this was not obta ined in 
these experiments. The rapidity (1 day) with which linoleate 
corrected the barrier abnormality suggests a direct local effect, 
but it is theoretically possible, though unlikely, that sufficient 
prostaglandins are generated locally [23,28,29] to normalize 
differentiation and barrier function. In contrast, oleic acid 
caused deterioration in barrier function. Although t he cause of 
this effect remains unknown, it may reflect increased bioavail-
ability of monoenoic acid precursors for conversion to eicosa-
trienoic acid, which, in turn, might further aggravate barrier 
function. In 2 recent studies topical linoleate did not effect 
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arachidonic acid levels after 5 days [30], and even after 14 days 
pros taglandin levels did not return to normal [20]. Thus, it is 
likely t hat the rapid, localized return to normal observed here 
reflects a specific effect of linoleic acid rather than a secondary 
response to normalized prostaglandin levels. 
Second, topical or systemically administered linoleic acid 
corrected defective ban-ier function, even over substantial phar-
macologic blockade of prostaglandin biosynthesis. These stud-
ies extend earlier observations, where the barrier was con-ected 
by linoleate over indomethacin blockade [26], but in the earlier 
study much lower (0.5 mg/ kg) and more infrequent (every other 
day) doses of indomethacin were given than in this study. 
Furthermore, in this study we also attempted to inhibit the 
lip oxygenase pathway, in addition to the cyclo-oxygenase path-
way, by administering tetrayenoic acid, an effective inhibitor of 
arachidonic acid metabolism [21]. This distinction is important 
because certain hydroxy fatty acid metabolites of the lipoxy-
genase pathway of arachidonic acid meta bolism may be regu-
lators of epidermal differentiation [31]. Although these experi-
ments lend furth er support for a direct role of linoleic acid, the 
possibility still remains tha t the low levels of prostaglandins 
that continue to be generated (Table, reference 20) may still be 
sufficient to normalize epidermal differentiation. 
In view of the general importance of lipids for barrier func-
tion, and for the seeming special role for linoleic acid, it is 
curious that there is not an overbundance of linoleate in stratum 
corneum lipids [15,32,33]. However, linoleic acid is found in 
disproportionate large amounts in certain mouse, porcine, and 
human epidermal sphingolipids [32-34], which have been im-
plicated as being of importance for the maintenance of the 
intercellular lipid bilayers in the stratum corneum [32,33]. 
Studies are currently underway in this laboratory to determine 
whether these compounds Ill"e altered specifically in EFAD. 
We gratefully acknowledge the technical assistance of Dr. Antoinette 
Born and the exper t preparation of the manuscript by William Chap-
man. Drs. John Voorhees and Dr. Jon Goerke provided valuable advice 
during t hese studies, and Dr. Mary A. Williams, Depar tment of NutI'i-
t iona I Sciences, University of Cali fornia, Berkeley, Cali fornia, prepared 
the diets. 
REFERENCES 
1. Alfin-Slater RB: Essential fa tty acids-R ecent developmen ts, Lipid 
Pharmacology, Vol. II . 1976, P 43- 82 
2. Holman RT: Essential fatty acids in human nutri t ion, International 
Sym'posium on Function and Biosynthesis of Lipids. Adv Exp 
Med BioI 83:515-534, 1977 
3. Basnajake V, Sinclair HM: The effects of deficiency of essent ial 
fatty acids upon the skin, Biochemical Problems of Lipids. Edited 
by G Popja k, E LeBreton. London, Butterworth, 1956, pp 476-
484 
4. E lias PM, Brown BE: The mammalian cutaneous permeability 
barrier: Defective barrier fun ction in essential fatty acid defi-
ciency correlates with abnormal intercellular lipid deposition. 
Lab Invest 39:574- 583, 1978 
5. Lowe NJ, Stoughton RB: Essential fatty acid deficient hairless 
mouse: A model of chl'onic epidermal hyperproliferation. Br J 
Dermatol 96:155-162, 1977 
6. Men ton DN: The effects of essential fatty ac id deficiency on the 
skin of the mouse. Am J Anat 122:337- 356, 1968 
7. Prottey C: Essential fatty acids and the skin. Br J Dermatol 94: 
579-587, 1976 
8. Friedman Z, Shocha t SJ , Maisels J, Mru'ks KH, Lamber th EL: 
Correction of essential fatty ac id deficiency in newborn infants 
by cutaneous application of sunflower-seed oil. Pediatrics 58:630-
634, 1976 
9. Press M, Har top PJ, Prottey C: Correction of essent ial fatty acid-
PERMEABILITY BARRIER 233 
deficiency in man by the cutaneous application of sunflower-seed 
oil. Lancet 1:597-599, 1974 
10. Prottey C, Hartop PJ , Press M: Correction of the cutaneous man-
ifestations of essential fatty acid deficiency in man by the appli-
cation of sunflower-seed oil to the skin. J Invest Dermatol 64: 
228-234, 1975 
11. Ziboh V A, Hsia SL: Effects of prostaglandin E2 on rat skin: Inhi-
bition of sterol ester biosynthesis and clearing of scaly lesions in 
essential fatty acid deficiency. J Lipid Res 13:458-467, 1972 
12. Willia ms MA, Tarnai KT, Hincenbergs I, McIntosh DJ: Hydrogen-
ated coconut oil and tissue fatty acids in EF A-depleted and EFA-
supplemented rats. J Nutr 102:847-856, 1972 
13. Thiels FAJ , Schutter K: Moisture meters for measuring the water 
balance of the human skin. Proc Toilet Goods Assoc 40:20, 1963 
14. Bligh EG, Dyer WJ : A rapid method of total lipid extraction and 
purification. Canad J Biochem Physiol 37:91l- 917, 1959 
15. Elias PM, Goerke J , Friend DS: Mammalian epidermal barrier 
lipids: Composition and influence on structure. J Invest Dermatol 
69:535-546, 1977 
16. Fulco AJ, Mead JF: Metabolism of essential fatty acids. VII. Origin 
of 5,8,11 eicosatrienoic acid in the fatty acid deficient rat. J Bioi 
Chem 234:1411-1416, 1959 
17. Ziboh VA: Biosynthesis of prostaglandin E2 in human skin: Sub-
cellular localization and inhibition by unsaturated fatty ac ids and 
antiinflammatory drugs. J Lipid Res 14:377- 384, 1973 
18. Bergstrom S, Dressler F, Krabisch L, Ryhage R, Sjovall J : The 
isolation and structure of a smooth muscle stimulating factor in 
normal sheep and pig lungs. Prostaglandin and related factors. 9. 
Ark Kemi 20:63-66, 1963 
19. Bergstrom S, Ryhage R, Samuelsson B, Sjovall S: Prostaglandin 
and related factors. 15. The structures of prostaglandin E" F'n 
and F,p. J Bioi Chem 238:3555-3546, 1963 
20. Lowe NJ , DeQuoy PR: Linoleic acid effects on epidermal DNA 
synthesis and cutan eous prostaglandin levels in essential fatty 
acid deficiency. J Invest Dermatol 70:200-203, 1978 
21. Flower RJ: Drugs which inhibit prostaglandin biosynthesis. Phar-
macol Rev 26:33-67, 1974 
22. Hammerstom S, Lindgren JA, Marcelo C, Duell EA, Anderson TF, 
Voorhees JJ: Arachidonic acid transformations in normal and 
psoriatic skin. J Invest Dermatol 73:180-1 93, 1979 
23. Sadowski JA: Metabolism and release of ru'achidonic acid by pri-
mru'y mouse epidermal cell cultures. Fed Proc 38:752a, 1979 
24. VanDorp DA: Essential fa tty acids and prostaglandins, 24th Inter-
national Congress of P ure and Applied Chemistry, Vol. 2. Lon-
don, Butterworth , 1974, p 117 
25. PI'ottey C, Hru"t.op PJ, Black JG, M cCormack JI: T he repair of 
impaired epidermal barrier function in rats by the cutaneous 
application of linoleic acid. Br J Dermatol 94:13- 21, 1976 
26. Prottey C: Investigaion of functions of essent ial fatty acids in the 
skin. Br J D erma tol 97:29-38, 1977 
27. J elenko C, Wheeler ML, Scott TH: Studies in burns. X. Ethyl 
linoleate: The water-holding lipid of skin. A. The evidence. J 
Trauma 12:968-977, 1972 
28. Jonsson CE, Anggard E: Biosynthesis and metabolism of prosta-
glandin E2 in human skin. Scand J Clin Lab Invest 29:289-296, 
1972 
29. Ziboh VA: Biosynthesis of prostaglandin E 2 in human skin: Sub-
cellular localization and inhibi tion by unsatura ted fatty acids and 
anti-inflammatory w·ugs. J Lipid Res 14:377- 384, 1973 
30. Hru·top PJ, Prottey C: Changes in transepidermal water loss and 
the composition of epidermal lecithin after application of pure 
fatty acid triglycerides to the skin of essential fatty acid-deficient 
rats. Br J Dermatol 95:255-264, 1976 
31. Hammerstrom S, Hamberg M, Sammuelsson B, Duell EA, Stawiski 
M, Voorhees JJ: Increased concentrations of nonesterified ru'ach-
idonic acid, 12, 1-hyw'oxy-5,8,1D,14-eicosatrienoic acid, prosta-
gla ndin E 2, and prostaglandin F2• in epidermis of psoriasis. Proc 
Nat! Acad Sci 82:5130- 5134. 1975 
32. Elias PM, Brown BE, Goerke J , Fritsch P , Gray GM, White RJ: 
Localization and composition of lipids in neonatal mouse stratum 
granulosum and stratum corneum. J Invest Dermatol 73:339-
348, 1979 
33. Gray GM , White RJ : Glycosphingolipids and ceramides in human 
and pig epidermis. J Invest Dermatol 70:336-341, 1978 
34. Gray GM, White RJ , Majer RJ : 1-(3'-O'acyl) -,8-glucosyl-N-dihy-
w'oxy-pen tatriacon tadienoylsphingosine, a major component of 
the glucosylceran1ides of pig and human epidermis. Biochim Acta 
528:127-137, 1978 
